Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
The Lancet. Oncology
|
February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report
Terri S Armstrong, Linda Dirven, David Arons, et al.
Investigational New Drugs
|
June 28, 2021
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors
Shivaani Kummar, Apurva K Srivastava, Tony Navas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies
Shivaani Kummar, Robert Kinders, Martin E Gutierrez, et al.
Journal of the National Cancer Institute. Monographs
|
November 16, 2017
State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report
Dan Xi, Ting Bao, Qi Chen, et al.
Cancer Research
|
July 29, 2011
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas
Shivaani Kummar, Alice Chen, Jiuping Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2012
A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas
Shivaani Kummar, Jiuping Ji, Robert Morgan, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2016
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors
Shivaani Kummar, Alice Chen, Martin Gutierrez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2025
A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors
Sarah J Shin, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2013
Developing safety criteria for introducing new agents into neoadjuvant trials
Angela DeMichele, Donald A Berry, JoAnne Zujewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2021
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors
Naoko Takebe, Abdul Rafeh Naqash, Geraldine O'Sullivan Coyne, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
The Lancet. Oncology
|
February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report
Terri S Armstrong, Linda Dirven, David Arons, et al.
Investigational New Drugs
|
June 28, 2021
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors
Shivaani Kummar, Apurva K Srivastava, Tony Navas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies
Shivaani Kummar, Robert Kinders, Martin E Gutierrez, et al.
Journal of the National Cancer Institute. Monographs
|
November 16, 2017
State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report
Dan Xi, Ting Bao, Qi Chen, et al.
Cancer Research
|
July 29, 2011
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas
Shivaani Kummar, Alice Chen, Jiuping Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2012
A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas
Shivaani Kummar, Jiuping Ji, Robert Morgan, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2016
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors
Shivaani Kummar, Alice Chen, Martin Gutierrez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2025
A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors
Sarah J Shin, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2013
Developing safety criteria for introducing new agents into neoadjuvant trials
Angela DeMichele, Donald A Berry, JoAnne Zujewski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2021
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors
Naoko Takebe, Abdul Rafeh Naqash, Geraldine O'Sullivan Coyne, et al.
Page
of 6